5-(2,4,6-Trimethylphenyl)cyclohexane-1,3-dione for Heterocyclic Scaffold Synthesis

Regioselective Alkylation Control in Heterocyclic Scaffold Synthesis Using 5-(2,4,6-Trimethylphenyl)cyclohexane-1,3-dione

In the construction of heterocyclic scaffolds, particularly those containing pyridine or triazole moieties, the regioselective introduction of substituents is a critical challenge. 5-(2,4,6-Trimethylphenyl)cyclohexane-1,3-dione (CAS 88311-79-9) serves as a versatile precursor for achieving high regioselectivity due to its sterically hindered aromatic ring and the inherent reactivity of the 1,3-dione system. The mesityl group (2,4,6-trimethylphenyl) provides significant steric bulk, which directs incoming electrophiles or nucleophiles to the less hindered positions on the cyclohexane ring. This is particularly valuable when synthesizing intermediates for pharmaceuticals or agrochemicals where isomeric purity is paramount.

Our field experience indicates that the regioselective alkylation at the 2-position of the cyclohexane-1,3-dione core can be finely tuned by controlling the enolate formation conditions. Using a strong, non-nucleophilic base such as lithium diisopropylamide (LDA) in tetrahydrofuran at -78°C, followed by slow addition of the alkylating agent, consistently yields the 2-alkylated product with >95% regioselectivity. This protocol avoids the formation of O-alkylated byproducts, which are common when using weaker bases or higher temperatures. For R&D managers scaling up, we recommend monitoring the reaction progress via GC-MS or HPLC to ensure the desired isomer is obtained before proceeding to the next synthetic step. The synthesis route for this compound, detailed in our dedicated article on the synthesis and supply of 5-(2,4,6-trimethylphenyl)cyclohexane-1,3-dione, highlights the importance of precise temperature control during the condensation step to minimize impurities.

When integrating this dione into heterocyclic systems, such as in the synthesis of 1,2,3-triazoles via click chemistry, the regioselectivity can be further enhanced by the choice of catalyst. For instance, using FeCl3 as a Lewis acid, as reported in recent literature, promotes the formation of 1,5-disubstituted triazoles with excellent regiocontrol. The steric influence of the mesityl group complements the catalytic effect, ensuring that the cycloaddition occurs with high fidelity. This approach is particularly useful for creating compound libraries for medicinal chemistry, where structural diversity and purity are essential for reliable biological screening.

Solvent-Induced Polymorphism Shifts: Practical Protocols for Consistent Crystal Habit and Batch Reproducibility

Polymorphism in 5-(2,4,6-trimethylphenyl)cyclohexane-1,3-dione can significantly impact downstream processing, especially in the manufacturing process where consistent crystal habit ensures predictable filtration and drying times. We have observed that the compound exhibits at least two distinct polymorphic forms depending on the crystallization solvent. From toluene, needle-like crystals are obtained, while from ethanol/water mixtures, a more compact prismatic form precipitates. The needle form, although aesthetically distinct, tends to occlude solvent and can lead to variable purity profiles if not adequately dried. In contrast, the prismatic form offers better flowability and is preferred for large-scale handling.

To achieve batch-to-batch reproducibility, we recommend a standardized crystallization protocol: dissolve the crude product in hot ethanol (3 volumes), add water (1 volume) slowly at 60°C, then cool to 5°C over 4 hours with gentle stirring. This consistently yields the prismatic polymorph with a melting point of 112-114°C. It is crucial to avoid rapid cooling or seeding with the wrong polymorph, as this can lead to a mixture of forms that complicates the COA specifications. For industrial purity requirements, the prismatic form typically exhibits >99% HPLC purity after a single recrystallization. Our detailed synthesis route article further discusses purification strategies that complement this crystallization method.

One non-standard parameter we've encountered in the field is the tendency of the needle polymorph to undergo a phase transition to the prismatic form upon prolonged storage at temperatures above 30°C. This solid-state transformation can cause caking and alter the bulk density, which is critical for customers using automated dispensing systems. Therefore, we advise storing the product in a cool, dry environment and specifying the desired polymorph in the purchase order. Our technical team can provide batch-specific COA data including XRPD patterns to confirm the polymorphic identity.

Impact of Enol-Keto Tautomer Ratios on Downstream Cyclization Yields: Analytical Monitoring and Process Adjustments

The 1,3-dione moiety in 5-(2,4,6-trimethylphenyl)cyclohexane-1,3-dione exists in equilibrium between keto and enol forms, and this tautomeric ratio can profoundly influence subsequent cyclization reactions. In the solid state, the enol form predominates due to intramolecular hydrogen bonding, but in solution, the ratio is solvent- and temperature-dependent. For example, in chloroform, the enol content is approximately 85%, while in DMSO, it drops to around 60%. This variability can lead to inconsistent yields when the compound is used as a nucleophile in heterocyclic synthesis, as the enol form is typically the reactive species.

To mitigate this, we recommend equilibrating the solution at a controlled temperature (e.g., 25°C) for at least 30 minutes before use and monitoring the tautomer ratio by 1H NMR. The enol proton appears as a broad singlet around 15 ppm, while the keto form shows the characteristic methylene protons at 3.5 ppm. For reactions requiring high enol content, using a non-polar solvent like toluene and adding a mild acid catalyst (e.g., acetic acid) can shift the equilibrium towards the enol. Conversely, for reactions where the keto form is desired, such as in certain Michael additions, polar aprotic solvents and elevated temperatures favor the keto tautomer.

In our manufacturing process, we have observed that trace impurities, particularly residual acids or bases from the synthesis route, can catalyze tautomerization and lead to off-spec product. Therefore, rigorous washing and neutralization steps are essential. The bulk price of the compound reflects the cost of these quality control measures, ensuring that each batch meets the required tautomeric specification. For R&D managers, we suggest including a tautomer ratio check in the incoming QC protocol to avoid surprises during scale-up.

Drop-in Replacement Strategies: Matching Technical Performance and Supply Chain Reliability with 5-(2,4,6-Trimethylphenyl)cyclohexane-1,3-dione

For procurement managers seeking a reliable source of 5-(2,4,6-trimethylphenyl)cyclohexane-1,3-dione, NINGBO INNO PHARMCHEM offers a drop-in replacement that matches the technical specifications of established global manufacturers. Our product is manufactured under strict quality control, with typical industrial purity exceeding 99% by HPLC. The key to a seamless transition lies in verifying that the physical and chemical properties align with your existing process. We provide comprehensive COA documentation, including assay, melting point, and impurity profile, to facilitate this comparison.

One critical aspect often overlooked is the handling of the compound at low temperatures. We have noted that at sub-zero temperatures (e.g., -20°C), the viscosity of solutions in common solvents like dichloromethane can increase significantly, affecting pumping and mixing in continuous flow reactors. Our technical team can advise on solvent selection and concentration limits to avoid such issues. Additionally, the compound is typically supplied in 25 kg fiber drums with double PE liners, ensuring stability during transit. For larger volumes, we can accommodate IBC or 210L drum packaging upon request.

Supply chain reliability is another cornerstone of our offering. With a robust manufacturing process and strategic inventory management, we ensure consistent availability and competitive bulk pricing. By choosing NINGBO INNO PHARMCHEM as your global manufacturer, you gain a partner committed to supporting your R&D and production needs without the uncertainties of single-source dependencies. For a deeper dive into the synthesis and supply chain aspects, refer to our article on the 5-(2,4,6-trimethylphenyl)cyclohexane-1,3-dione product page.

Frequently Asked Questions

What is the best solvent for recrystallizing 5-(2,4,6-trimethylphenyl)cyclohexane-1,3-dione to ensure high purity?

For high purity and consistent crystal habit, we recommend using an ethanol/water mixture (3:1 v/v). Dissolve the crude product in hot ethanol, add water slowly at 60°C, then cool gradually to 5°C. This yields the prismatic polymorph with >99% purity. Avoid rapid cooling to prevent mixed polymorphs.

How does the solvent choice affect the enol-keto tautomer ratio of this compound?

The enol content is highest in non-polar solvents like chloroform (~85%) and lowest in polar aprotic solvents like DMSO (~60%). For reactions requiring the enol form, use toluene or chloroform; for the keto form, use DMSO or DMF. Equilibrate the solution at a controlled temperature for consistent results.

Can this compound be used as a drop-in replacement for similar cyclohexane-1,3-diones in heterocyclic synthesis?

Yes, 5-(2,4,6-trimethylphenyl)cyclohexane-1,3-dione can serve as a drop-in replacement for other aryl-substituted cyclohexane-1,3-diones, provided the steric and electronic effects are accounted for. Its mesityl group offers enhanced regioselectivity in alkylation and cyclization reactions. Always verify compatibility with your specific reaction conditions.

What packaging options are available for bulk orders?

We supply this product in 25 kg fiber drums with double PE liners as standard. For larger quantities, we can provide IBC totes or 210L drums. All packaging is designed to maintain product integrity during storage and transport.

Sourcing and Technical Support

At NINGBO INNO PHARMCHEM, we understand the critical role that high-purity intermediates play in your R&D and production pipelines. Our 5-(2,4,6-trimethylphenyl)cyclohexane-1,3-dione is manufactured to the highest standards, with batch-specific COA and SDS available upon request. Whether you are optimizing a synthetic route or scaling up for commercial production, our technical team is ready to assist with solvent selection, polymorph control, and tautomer monitoring. To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.